Monthly Archives: May 2018

Talon Metals announced results for three months ended March 31, 2018

Talon Metals Corp. announced financial results for the three months ended March 31, 2018. For this period, the BVI company reported net loss of US$2.0mln, or US$0.02 per share (basic and diluted). This result compares to the net loss of US$1.9mln or US$0.01 per share for the three months ended March 31, 2017. Both results were primarily due to the loss on the fair value revaluation of the Resource Capital Fund VI L.P. unsecured convertible loan and administration expenses.

For the three months ended March 31, 2018, capitalized exploration costs and deferred expenditures on the Tamarack Nickel-Copper-PGE Project amounted to US$0.2mln, as compared to US$1.0mln for the same period of the previous year. The total capitalized exploration cost on the Tamarack NIckel-Copper-PGE Project to March 31, 2018 was US$39.1mln.

BVI holding invests in US biotech company

The US biotechnology firm LyGenesis announced that the investment was made by the British Virgin Islands-registered holding company Juvenescence Ltd., in the amount of US$3 million.
LyGenesis is working with lymph nodes to regrow functioning organs with patient’s own body, focusing on patients with end-stage liver condition, and the investment will enable the completion of work required for human clinical trials.

LyGenesis was established on the basis of academic research, which was partially funded by the National Institutes of Health and conducted at Pittsburgh’s McGowan Institute for Regenerative Medicine, and revealed that a variety of different cells types and tissues, including the liver, could engraft and grow within lymph nodes. LyGenesis licensed patents for the technology from Pittsburgh.